Search results
Search results from www.aesgp.eu
| Ingredient | ATC Level 1 | ATC Level 2 | Year Of Switch | Country | Status | Additional Information |
|---|---|---|---|---|---|---|
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Argentina | Rx | — |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Australia | OTC | S2 |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Austria | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Belgium | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Bulgaria | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2005 | Canada | OTC | — |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Chile | Rx | — |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | China | Rx | — |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Colombia | OTC | Maximum strength 50g/100ml in syrup. |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Croatia | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Czech Republic | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Denmark | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Estonia | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Finland | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | France | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Germany | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Greece | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Hungary | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Ireland | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Italy | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Japan | Rx | — |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Lithuania | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Mexico | — | No information. |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | New Zealand | — | No information. |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Norway | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union (as well as Norway and Iceland) through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Philippines | — | No information. |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Poland | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Portugal | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Romania | Rx | Pharmaceutical forms - oral solution, orodispersible tablets, tablets, solution, oral lyophilisate For tablets formulation: daily dose for adults and children above 12 years is one tablet For oral solution: children between 1-5 years old: 2.5 ml daily For children between 6 and 11 years old: 5 ml daily |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Russia | OTC | Tablets and syrup for the treatment of chronic idiopathic urticaria. |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Singapore | — | No information. |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Slovak Republic | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Slovenia | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | South Korea | — | No information. |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Spain | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Sweden | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | Switzerland | OTC | Tablets; 5 mg; 1 month's treatment; For children above six years |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | The Netherlands | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | UK | Rx | — |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | USA | Rx | — |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | Venezuela | Rx | — |
- 41 ingredients